Patents by Inventor Bruce A. Bach

Bruce A. Bach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vehicle diagnostics with intelligent communication interface
    Patent number: 11915534
    Abstract: A method of providing vehicle diagnostics may include receiving a first communication from a user, processing the first communication using a natural language processing (NLP) model to produce NLP model output including a sequence of words, extracting one or more keywords from the sequence of words, and instructing a data acquisition and transfer device (DAT) connected to an OBD port of a vehicle to perform a selected function based on the one or more keywords. The method may further include receiving diagnostic data from the DAT, the diagnostic data having been retrieved from the vehicle by the DAT in accordance with the selected function, and determining a diagnostic condition of the vehicle based on the diagnostic data.
    Type: Grant
    Filed: June 2, 2023
    Date of Patent: February 27, 2024
    Assignee: Innova Electronics Corporation
    Inventors: Phuong Pham, Ly Bach, Van Nguyen, Bruce Brunda
  • TREATMENT OF NON-SMALL CELL LUNG CANCER
    Publication number: 20200129482
    Abstract: The present invention provides methods of treating non-small cell lung cancer in a patient comprising administering to the patient an effective amount of a PARP inhibitor, wherein the patient is Lung Subtyping Panel (LSP) positive.
    Type: Application
    Filed: June 26, 2018
    Publication date: April 30, 2020
    Applicant: AbbVie Inc.
    Inventors: Peter Ansell, Lei He, Xin Huang, Vasudha Sehgal, Bruce Bach
  • Biomarker of Survival in the Treatment of Renal Cell Carcinoma with a VEGFR Inhibitor and an Ang2 Inhibitor
    Publication number: 20190004048
    Abstract: The present invention relates to methods, compositions, and kits for using placental growth factor (PLGF) as an informative biomarker in determining the clinical benefit to renal cell carcinoma patients by treatment with a VEGFR inhibitor and an Ang2 inhibitor.
    Type: Application
    Filed: June 22, 2016
    Publication date: January 3, 2019
    Applicant: AMGEN INC.
    Inventors: Abraham Antonio ANDERSON, Bruce A. BACH, Cheryl A. PICKETT-GIES, Michael B. BASS
  • Detecting immunological changes in HIV infected patient samples
    Patent number: 5156951
    Abstract: The present invention comprises a method for detecting immunological changes in blood samples from patients infected with HIV. The method comprises the use of fluorescently labelled monoclonal antibodies against IL-2R (CD25). Other antibodies, including anti-CD3, anti-CD38 and anti-HLA DR antibodies also may be used. It has been found that a decrease in expression of CD25 in such samples indicates HIV infection.
    Type: Grant
    Filed: July 13, 1989
    Date of Patent: October 20, 1992
    Assignee: Becton Dickinson and Company
    Inventors: Bruce A. Bach, Noel L. Warner, Anne Jackson